166 related articles for article (PubMed ID: 21745101)
21. β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation.
Boutin A; Eliseeva E; Gershengorn MC; Neumann S
FASEB J; 2014 Aug; 28(8):3446-55. PubMed ID: 24723693
[TBL] [Abstract][Full Text] [Related]
22. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
24. A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes.
Lado-Abeal J; Castro-Piedras I; Palos-Paz F; Labarta-Aizpún JI; Albero-Gamboa R
Thyroid; 2011 Feb; 21(2):103-9. PubMed ID: 21186955
[TBL] [Abstract][Full Text] [Related]
25. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
26. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
Sanders J; Miguel RN; Furmaniak J; Smith BR
Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
[TBL] [Abstract][Full Text] [Related]
27. The functional expression of recombinant human thyrotropin receptors in nonthyroidal eukaryotic cells provides evidence that homologous desensitization to thyrotropin stimulation requires a cell-specific factor.
Chazenbalk GD; Nagayama Y; Kaufman KD; Rapoport B
Endocrinology; 1990 Sep; 127(3):1240-4. PubMed ID: 2167212
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin Receptor: Allosteric Modulators Illuminate Intramolecular Signaling Mechanisms at the Interface of Ecto- and Transmembrane Domain.
Marcinkowski P; Kreuchwig A; Mendieta S; Hoyer I; Witte F; Furkert J; Rutz C; Lentz D; Krause G; Schülein R
Mol Pharmacol; 2019 Oct; 96(4):452-462. PubMed ID: 31399504
[TBL] [Abstract][Full Text] [Related]
29. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In Vitro.
Neumann S; Eliseeva E; Boutin A; Barnaeva E; Ferrer M; Southall N; Kim D; Hu X; Morgan SJ; Marugan JJ; Gershengorn MC
J Pharmacol Exp Ther; 2018 Jan; 364(1):38-45. PubMed ID: 29089368
[TBL] [Abstract][Full Text] [Related]
31. The expression of the thyroid-stimulating hormone (TSH) receptor and the cAMP-dependent protein kinase RII beta regulatory subunit confers TSH-cAMP-dependent growth to mouse fibroblasts.
Porcellini A; Messina S; De Gregorio G; Feliciello A; Carlucci A; Barone M; Picascia A; De Blasi A; Avvedimento EV
J Biol Chem; 2003 Oct; 278(42):40621-30. PubMed ID: 12902333
[TBL] [Abstract][Full Text] [Related]
32. Functional studies of new TSH receptor (TSHr) mutations identified in patients affected by hypothyroidism or isolated hyperthyrotrophinaemia.
De Marco G; Agretti P; Camilot M; Teofoli F; Tatò L; Vitti P; Pinchera A; Tonacchera M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):335-8. PubMed ID: 18727713
[TBL] [Abstract][Full Text] [Related]
33. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy.
Marcinkowski P; Hoyer I; Specker E; Furkert J; Rutz C; Neuenschwander M; Sobottka S; Sun H; Nazare M; Berchner-Pfannschmidt U; von Kries JP; Eckstein A; Schülein R; Krause G
Thyroid; 2019 Jan; 29(1):111-123. PubMed ID: 30351237
[TBL] [Abstract][Full Text] [Related]
34. Dominant negative effect of mutated thyroid stimulating hormone receptor (P556L) causes hypothyroidism in C.RF-Tshr(hyt/wild) mice.
Endo T; Kobayashi T
PLoS One; 2012; 7(8):e42358. PubMed ID: 22916127
[TBL] [Abstract][Full Text] [Related]
35. The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH.
Jaeschke H; Schaarschmidt J; Günther R; Mueller S
Endocrinology; 2011 Oct; 152(10):3986-96. PubMed ID: 21846801
[TBL] [Abstract][Full Text] [Related]
36. Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor.
Titus S; Neumann S; Zheng W; Southall N; Michael S; Klumpp C; Yasgar A; Shinn P; Thomas CJ; Inglese J; Gershengorn MC; Austin CP
J Biomol Screen; 2008 Feb; 13(2):120-7. PubMed ID: 18216391
[TBL] [Abstract][Full Text] [Related]
37. Role of asparagine-linked oligosaccharides in protein folding, membrane targeting, and thyrotropin and autoantibody binding of the human thyrotropin receptor.
Nagayama Y; Namba H; Yokoyama N; Yamashita S; Niwa M
J Biol Chem; 1998 Dec; 273(50):33423-8. PubMed ID: 9837919
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization of five constitutively activating thyrotrophin receptor mutations.
Wonerow P; Chey S; Führer D; Holzapfel HP; Paschke R
Clin Endocrinol (Oxf); 2000 Oct; 53(4):461-8. PubMed ID: 11012571
[TBL] [Abstract][Full Text] [Related]
39. Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.
Haas AK; Kleinau G; Hoyer I; Neumann S; Furkert J; Rutz C; Schülein R; Gershengorn MC; Krause G
Cell Mol Life Sci; 2011 Jan; 68(1):159-67. PubMed ID: 20652618
[TBL] [Abstract][Full Text] [Related]
40. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
